Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
Circulation
|
February 19, 2004
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
B Delia Johnson, Kevin E Kip, Oscar C Marroquin, et al.
Archives of Internal Medicine
|
May 13, 2009
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project
Martha Gulati, Rhonda M Cooper-DeHoff, Candace McClure, et al.
Journal of Women'S Health (2002)
|
April 14, 2009
The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study
Sarah E Linke, Thomas Rutledge, B Delia Johnson, et al.
American Heart Journal
|
June 24, 2010
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)
C Noel Bairey Merz, Marian B Olson, Candace McClure, et al.
International Journal of Cardiology
|
February 16, 2013
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
Thomas Rutledge, Tanya S Kenkre, Vera Bittner, et al.
Psychosomatic Medicine
|
March 22, 2012
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation study
Kerry S Whittaker, David S Krantz, Thomas Rutledge, et al.
Journal of Women'S Health (2002)
|
August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
International Journal of Cardiology. Heart & Vasculature
|
April 1, 2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE)
Erika Jones, B Delia Johnson, Leslee J Shaw, et al.
Journal of Behavioral Medicine
|
March 28, 2016
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
Thomas Rutledge, Tanya S Kenkre, Diane V Thompson, et al.
Journal of the American College of Cardiology
|
February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study
Eileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
Circulation
|
February 19, 2004
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
B Delia Johnson, Kevin E Kip, Oscar C Marroquin, et al.
Archives of Internal Medicine
|
May 13, 2009
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project
Martha Gulati, Rhonda M Cooper-DeHoff, Candace McClure, et al.
Journal of Women'S Health (2002)
|
April 14, 2009
The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study
Sarah E Linke, Thomas Rutledge, B Delia Johnson, et al.
American Heart Journal
|
June 24, 2010
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)
C Noel Bairey Merz, Marian B Olson, Candace McClure, et al.
International Journal of Cardiology
|
February 16, 2013
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
Thomas Rutledge, Tanya S Kenkre, Vera Bittner, et al.
Psychosomatic Medicine
|
March 22, 2012
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation study
Kerry S Whittaker, David S Krantz, Thomas Rutledge, et al.
Journal of Women'S Health (2002)
|
August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
International Journal of Cardiology. Heart & Vasculature
|
April 1, 2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE)
Erika Jones, B Delia Johnson, Leslee J Shaw, et al.
Journal of Behavioral Medicine
|
March 28, 2016
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
Thomas Rutledge, Tanya S Kenkre, Diane V Thompson, et al.
Journal of the American College of Cardiology
|
February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study
Eileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Page
of 9